Curriculum vitae for mark cushman - Purdue College of Pharmacy ...

32
Mark Cushman
51. "Synthesis and Anti-HIV Activity of Cosalane Analogs Incorporating Nitrogen in the
Alkenyl Linker Chain," 217th American Chemical Society National Meeting, March 22,
1999, Anaheim, California.
52. "Synthesis of New Analogs of Indenoisoquinoline: Potential Non-Camptothecin
Topoisomerase I Poisons," 217th American Chemical Society National Meeting, March
21, 1999, Anaheim, California.
53. "Synthesis of Analogs of Cosalane," 217th American Chemical Society National
Meeting, March 24, 1999, Anaheim, California.
54. "Novel Non-camptothecin Topoisomerase I Poisons: The Indenoisoquinolines," AACR-
NCI-EORTC International Conference on Molecular Targets and Cancer
Chemotherapeutics, November 16, 1999, Washington, D. C.
55. "Steroid Derivatives Interacting with Tubulin: from Colchicine-like to Paclitaxel-like
Effects on Tubulin Polymerization," AACR-NCI-EORTC International Conference on
Molecular Targets and Cancer Chemotherapeutics, November 16, 1999, Washington, D.
C.
56. "Inhibition of RANTES/CCR1 Mediated Chemotaxis by Novel Cosalane Compounds,"
Seventh Annual Conference of the International Cytokine Society, Hilton Head Island,
South Carolina, December 5, 1999.
57. "Novel Modifications to the Alkenyldiarylmethane (ADAM) Series of HIV-1 Reverse
Transcriptase Inhibitors," 219 th American Chemical Society National Meeting, San
Francisco, March 26, 2000.
58. "Cleavage Complexes Induced by Novel Non-Camptothecin Inhibitors, the
Indenoisoquinolines, in the Presence of Normal and Mutated Topoisomerase I from
Camptothecin-Resistant Cell Lines," 91 st Annual Meeting of the American Society for
Cancer Research, San Francisco, April 3, 2000.
59. "Synthesis of Cosalane Amino Acid Conjugates for Enhanced Anti-HIV Activity and
Oral Bioavailability," 221 st National Meeting of the American Chemical Society, San
Diego, April 1, 2001.
60. "Synthesis and Biological Evaluation of New Lavendustin A Analogs," 221 st National
Meeting of the American Chemical Society, San Diego, April 1, 2001.
61. "Solid Phase Synthesis of Alkenyldiarylmethanes Targeting HIV-1 Reverse
Transcriptase," 221 st National Meeting of the American Chemical Society, San Diego,
April 1, 2001.
62. "Design, Synthesis, and Biological Evaluation of Diarylmethylenepiperidinecarboxylates
as New Anti-HIV Agents," 221 st National Meeting of the American Chemical Society,
San Diego, April 1, 2001.
63. "Design and Synthesis of Brefeldin A Prodrugs with Enhanced Aqueous Solubilities,"
34 th Mid-Atlantic Graduate Student Symposium, Columbus, Ohio, June 28, 2001.
64. "Design and Synthesis of (+)-Brefeldin A Sulfide Prodrugs with Enhanced Aqueous
Solubilities," 222nd ACS National Meeting, Chicago, Illinois, August 26, 2001.
65. "Design and Synthesis of Novel Non-Camptothecin Topoisomerase I Poisons," 222nd
ACS National Meeting, Chicago, Illinois, August 26, 2001.
66. "Unexpected Aldol Type Addition Reaction of Diisopropylidene-D-Ribose Dithioacetal
and Regioselective 1-O-Deacylation of Peracetylated Glycopyranosides by Mercuric
Chloride and Mercuric Oxide," 222nd ACS National Meeting, Chicago, Illinois, August
27, 2001.
67. "Extension of the Polyanionic Cosalane Chromophore for Increasing Anti-HIV Potency,"
222nd ACS National Meeting, Chicago, Illinois, August 26, 2001.